Blood Cancer Treatment Continues to Shift Away From Chemotherapy
Published: Thursday, Sep 05, 2019
Steven T. Rosen, MD
In recent years, successful trials exploring novel approaches such as targeted therapy, immunotherapy, and CAR T-cell therapy, have all revolutionized the way certain hematologic malignancies are treated. Newer agents are garnering the same, if not better, results than what has been seen with traditional approaches, such as chemotherapy, according to Steven T. Rosen, MD.
... to read the full story